Functional Activity of Cd34-Positive Cells in Chronic Myeloid Leukemia Patients With Different Response to Imatinib Therapy

Experimental Oncology - Ukraine
doi 10.31768/2312-8852.2015.37(1):70-72
Full Text
Abstract

Available in full text

Date
Authors
Publisher

LLC MORION

Related search

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

In Vitro Effects of Imatinib on CD34+ Cells of Patients With Chronic Myeloid Leukemia in the Megakaryocytic Crisis Phase

Oncology Letters
Cancer ResearchOncology
2014English

Polycomb Genes Are Associated With Response to Imatinib in Chronic Myeloid Leukemia

Epigenomics
Cancer ResearchGenetics
2015English

Therapy of Chronic Myeloid Leukemia: Twilight of the Imatinib Era?

ISRN Oncology
2014English

CD34+/Ph+ Cells Are Still Detectable in Chronic Myeloid Leukemia Patients With Sustained and Prolonged Complete Cytogenetic Remission During Treatment With Imatinib Mesylate

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Differentially Expressed Genes Responsible for Insensitivity of CD34+ Cells to Kinase Inhibitors in Patients With Chronic Myeloid Leukemia

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2013English

Imatinib and Plasmacytoid Dendritic Cell Function in Patients With Chronic Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients

2012English

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy